The alterations in asprosin, clusterin, ZAG, NF-κB, and PPAR-γ levels across the studied groups highlight the complex interplay of metabolic dysregulation and inflammation in T2DM. This evidence concerns the gene CLU and type 2 diabetes mellitus.